| 
                    Name | 
                         Mevinic acid 
                     | 
                
| Molecular Formula | C23H36O6 | |
| IUPAC Name* | 
                         (3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid 
                     | 
                |
| SMILES | 
                         CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O 
                     | 
                |
| InChI | 
                         InChI=1S/C23H36O6/c1-4-14(2)23(28)29-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-17(24)12-18(25)13-21(26)27/h6,8-9,14-15,17-20,22,24-25H,4-5,7,10-13H2,1-3H3,(H,26,27)/t14-,15-,17+,18+,19-,20-,22-/m0/s1 
                     | 
                |
| InChIKey | 
                         BOZILQFLQYBIIY-INTXDZFKSA-N 
                     | 
                |
| Synonyms | 
                         Mevinic acid; Mevastatin acid; Compactin acid; Mevastatin hydroxy acid; Mevastatin (acid form); ML 236B acid; 1R89KK61YI; 84064-38-0; (3r,5r)-3,5-Dihydroxy-7-[(1s,2s,8s,8ar)-2-Methyl-8-{[(2s)-2-Methylbutanoyl]oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl]heptanoic Acid; eptanoic acid; Compactic acid; ML-236B acid; UNII-1R89KK61YI; CHEMBL503456; SCHEMBL8191581; CHEBI:39508; ZINC4134477; Q27252788; (3R,5R)-3,5-dihydroxy-7-[(1S,2S,8S,8aR)-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]h; 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,.DELTA.-DIHYDROXY-2-METHYL-8-((2S)-2-METHYL-1-OXOBUTOXY)-, (.BETA.R,.DELTA.R,1S,2S,8S,8AR)-; 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2-methyl-8-((2S)-2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,8S,8aR)- 
                     | 
                |
| CAS | 84064-38-0 | |
| PubChem CID | 446154 | |
| ChEMBL ID | CHEMBL503456 | 
Chemical Classification: | 
                    
                        
  | 
                    
                        
                            
                     | 
                
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | 
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | 
| Molecular Weight: | 408.5 | ALogp: | 3.1 | 
| HBD: | 3 | HBA: | 6 | 
| Rotatable Bonds: | 11 | Lipinski's rule of five: | Accepted | 
| Polar Surface Area: | 104.0 | Aromatic Rings: | 2 | 
| Heavy Atoms: | 29 | QED Weighted: | 0.468 | 
| Caco-2 Permeability: | -5.383 | MDCK Permeability: | 0.00003340 | 
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.994 | 
| Human Intestinal Absorption (HIA): | 0.832 | 20% Bioavailability (F20%): | 0.994 | 
| 30% Bioavailability (F30%): | 0.99 | 
| Blood-Brain-Barrier Penetration (BBB): | 0.14 | Plasma Protein Binding (PPB): | 81.71% | 
| Volume Distribution (VD): | 0.52 | Fu: | 8.67% | 
| CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.055 | 
| CYP2C19-inhibitor: | 0.013 | CYP2C19-substrate: | 0.77 | 
| CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.556 | 
| CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.07 | 
| CYP3A4-inhibitor: | 0.162 | CYP3A4-substrate: | 0.63 | 
| Clearance (CL): | 13.857 | Half-life (T1/2): | 0.91 | 
| hERG Blockers: | 0.11 | Human Hepatotoxicity (H-HT): | 0.946 | 
| Drug-inuced Liver Injury (DILI): | 0.015 | AMES Toxicity: | 0.008 | 
| Rat Oral Acute Toxicity: | 0.079 | Maximum Recommended Daily Dose: | 0.986 | 
| Skin Sensitization: | 0.955 | Carcinogencity: | 0.586 | 
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.056 | 
| Respiratory Toxicity: | 0.951 | 
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC006006 | ![]()  | 
                    0.663 | D02RQU | ![]()  | 
                    0.778 | ||
| ENC000662 | ![]()  | 
                    0.539 | D06WTZ | ![]()  | 
                    0.420 | ||
| ENC006008 | ![]()  | 
                    0.495 | D0H0ND | ![]()  | 
                    0.309 | ||
| ENC006007 | ![]()  | 
                    0.427 | D01WUA | ![]()  | 
                    0.274 | ||
| ENC002580 | ![]()  | 
                    0.420 | D0C6NM | ![]()  | 
                    0.248 | ||
| ENC002912 | ![]()  | 
                    0.414 | D01QIN | ![]()  | 
                    0.236 | ||
| ENC000994 | ![]()  | 
                    0.412 | D03KIA | ![]()  | 
                    0.226 | ||
| ENC004385 | ![]()  | 
                    0.307 | D01STB | ![]()  | 
                    0.226 | ||
| ENC004384 | ![]()  | 
                    0.307 | D0ZI4H | ![]()  | 
                    0.225 | ||
| ENC005083 | ![]()  | 
                    0.289 | D0N3NO | ![]()  | 
                    0.224 | ||